LB Pharmaceuticals CFO Joseph M. Miller files initial beneficial ownership statement
LBRX•Initial Form 3 filing for new CFO
- LB Pharmaceuticals named Joseph M. Miller as chief financial officer in an initial Form 3 insider filing dated 09/02/2026.*
LBRX•
